Inflammatory mediators and glucose in pregnancy: Results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 12, 2010, Pages 5427-5434

  Lowe, Lynn P ^a   Metzger, Boyd E ^a   Lowe Jr , William L ^a   Dyer, Alan R ^a   McDade, Thomas W ^b   McIntyre, H David ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C PEPTIDE; C REACTIVE PROTEIN; GLUCOSE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN;

ADULT; ARTICLE; BIRTH WEIGHT; BODY FAT; BODY MASS; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GESTATION PERIOD; HUMAN; HYPERGLYCEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKINFOLD THICKNESS;

EID: 78650050456     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1662     Document Type: Article

References (40)

1. Dandona P, Aljada A, Bandyopadhyay A 2004 Inflammation: the link between insulin resistance, obesity, and diabetes. Trends Immunol 25:4-7
2. Richardson AC, Carpenter MW 2007 Inflammatory mediators in gestational diabetes. Obstet Gynecol Clin North Am 34:213-224
3. Bo S, Signorile A, Menato G, Gambino R, Bardelli C, Gallo ML, Cassader M, Massobrio M, Pagano GF 2005 C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia. J Endocrinol Invest 28:779-786
4. Kinalski M, Telejko B, KuŸmicki M, Kretowski A, Kinalska I 2005 Tumor necrosis factor α system and plasma adiponectin concentration in women with gestational diabetes. Horm Metab Res 37:450-454
5. Wolf M, Sauk J, Shah A, Vossen Smirnakis K, Jimenez-Kimble R, Ecker JL, Thadhani R 2004 Inflammation and glucose tolerance: a prospective study of gestational diabetes mellitus. Diabetes Care 27:21-27 (Pubitemid 38196704)
6. Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA 2004 Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 89:2306-2311 (Pubitemid 38619868)
7. Heitritter SM, Solomon CG, Mitchell GF, Skali-Ounis N, Seely EW 2005 Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 90:3983-3988 (Pubitemid 41058161)
8. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G 1999 Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353:1649-1652
9. HAPO Study Cooperative Research Group 2002 The hyperglycemia and adverse pregnancy outcome(HAPO)study. Int J Gynecol Obstet 78:69-77
10. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA 2008 Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991-2002
11. Nesbitt GS, Smye M, Sheridan B, Lappin TR, Trimble ER 2006 Integration of local and central laboratory functions in a worldwide multicentre study. Experience from the hyperglycemia and adverse pregnancy outcome (HAPO) study. Clin Trials 3:397-407
12. O'Rahilly S, Burnett MA, Smith RF, Darley JH, Turner RC 1987 Haemolysis affects insulin but not C-peptide immunoassay. Diabetologia 30:394-396.
13. Catalano PM, Thomas AJ, Avallone DA, Amini SB 1995 Anthropometric estimation of neonatal body composition. Am J Obstet Gynecol 173:1176-1181.
14. HAPO Study Cooperative Research Group 2010 Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. Br J Obstet Gynaecol 117:575-584
15. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva A, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI 2010 International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676-682
16. Haugel-de Mouzon S, Guerre-Millo M 2006 The placenta cytokine network and inflammatory signals. Placenta 27:794-798.
17. Struwe E, Berzl GM, Schild RL, Dötsch J 2009 Gene expression of placental hormones regulating energy balance in small for gestational age neonates. Eur J Obstet Gynecol Reprod Biol 142:38-42
18. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
19. Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knofler M, Bancher-Todesca D 2004 Decreased plasma adiponectin concentrations in women with gestational diabetes Am J Obstet Gynecol 191:2120-2124
20. Cseh K, Baranyi E, Melczer Z, Kaszás E, Palik E, Winkler G 2004 Plasma adiponectin and pregnancy-induced insulin resistance. Diabetes Care 27:274-275
21. Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D, Pacini G, Funahashi T, Kautzky-Willer A 2004 Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27:1721-1727
22. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA 2004 Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 83:341-347
23. Atègbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K, Miled A, Grissa A, Jerbi M, Tabka Z, Khan NA 2006 Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 91:4137-4143
24. Lain KY, Daftary AR, Ness RB, Roberts JM 2008 First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf) 69:407-411
25. Lopez-Bermejo A, Fernandez-Real JM, Garrido E, Rovira R, Brichs R, Genaro P, Bach C, Cabrero D, Kihara S, Funahashi T, Vendrell J, Ricart W 2004 Maternal soluble tumour necrosis factor receptor type 2 (sTNFR2) and adiponectin are both related to blood pressure during gestation and infant's birthweight. Clin Endocrinol (Oxf) 61:544-552
26. Verhaeghe J, van Bree R, Van Herck E 2006 Maternal body size and birth weight: can insulin or adipokines do better? Metabolism 55:339-344
27. Tsai PJ, Yu CH, Hsu SP, Lee YH, Huang IT, Ho SC, Chu CH 2005 Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Nutrition 21:1095-1099
28. Kershaw EE, Flier JS 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556
29. Akinci B, Demir T, Saygili S, Yener S, Alacacioglu I, Saygili F, Bayraktar F, Yesil S 2008 Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy. Diabetes Res Clin Pract 81:93-96
30. Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A 2006 Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes. Eur J Clin Invest 36:345-352
31. Hu G, Jousilahti P, Tuomilehto J, Antikainen R, Sundvall J, Salomaa V 2009 Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a prospective Finnish study. J Clin Endocrinol Metab 94:2099-2105
32. Qiu C, Sorensen T, Luthy DA, Williams MA 2004 A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes. Paediatr Perinat Epidemiol 18:377-384 (Pubitemid 39304358)
33. HAPO Study Cooperative Research Group 2009 Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 58:453-459
34. Guven MA, Coskun A, Ertas IE, Aral M, Zencirci B, Oksuz H 2009 Association of maternal serum CRP, IL-6, TNF-α, homocysteine, folic acid and vitamin B12 levels with the severity of preeclampsia and fetal birth weight. Hypertens Pregnancy 28:190-200
35. Palik E, Baranyi E, Melczer Z, Audikovszky M, Szöcs A, Winkler G, Cseh K 2007 Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Res Clin Pract 76:351-357
36. Kuzmicki M, Telejko B, Szamatowicz J, Zonenberg A, Nikolajuk A, Kretowski A, Gorska M 2009 High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol 25:258-263
37. Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, Cetin I, Cortelazzi R, Beck-Peccoz P, Spada A 2007 Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf) 66:447-453
38. Megia A, Vendrell J, Gutierrez C, Sabaté M, Broch M, Fernández-Real JM, Simón I 2008 Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol 158:173-178
39. Jansson N, Nilsfelt A, Gellerstedt M, Wennergren M, Rossander- Hulthén L, Powell TL, Jansson T 2008 Maternal hormones linking maternal body mass index and dietary intake to birth weight. Am J Clin Nutr 87:1743-1749
40. Cho GJ, Yoo SW, Hong SC, Oh MJ, Kim T, Kim HJ, Lee KW, Kim SH 2006 Correlations between umbilical and maternal serum resistin levels and neonatal birth weight. Acta Obstet Gynecol Scand 85:1051-1056